Repository logo
 
Publication

Disclosing the antitumour potential of the marine bromoditerpene sphaerococcenol a on distinct cancer cellular models

dc.contributor.authorAlves, Celso
dc.contributor.authorSilva, Joana
dc.contributor.authorAfonso, Marta B.
dc.contributor.authorGuedes, Romina A.
dc.contributor.authorGuedes, Rita C.
dc.contributor.authorAlvariño, Rebeca
dc.contributor.authorPinteus, Susete
dc.contributor.authorGaspar, Helena
dc.contributor.authorGoettert, Marcia I.
dc.contributor.authorAlfonso, Amparo
dc.contributor.authorRodrigues, Cecília M. P.
dc.contributor.authorAlpoim, Maria C.
dc.contributor.authorBotana, Luis
dc.contributor.authorPedrosa, Rui
dc.date.accessioned2022-07-22T12:45:58Z
dc.date.available2022-07-22T12:45:58Z
dc.date.issued2022
dc.description.abstractNature has revealed to be a key source of innovative anticancer drugs. This study evaluated the antitumour potential of the marine bromoditerpene sphaerococcenol A on different cancer cellular models. Dose-response analyses (0.1–100 μM; 24 h) were accomplished in eight different tumour cell lines (A549, CACO-2, HCT-15, MCF-7, NCI-H226, PC-3, SH-SY5Y, SK-MEL-28). Deeper studies were conducted on MFC-7 cells, namely, determination of hydrogen peroxide (H2O2) levels and evaluation of apoptosis biomarkers (phosphatidylserine membrane translocation, mitochondrial dysfunction, Caspase-9 activity, and DNA changes). The ability of the compound to induce genotoxicity was verified in L929 fibroblasts. Sphaerococcenol A capacity to impact colorectal-cancer stem cells (CSCs) tumourspheres (HT29, HCT116, SW620) was evaluated by determining tumourspheres viability, number, and area, as well as the proteasome inhibitory activity. Sphaerococcenol A hepatoxicity was studied in AML12 hepatocytes. The compound exhibited cytotoxicity in all malignant cell lines (IC50 ranging from 4.5 to 16.6 μM). MCF-7 cells viability loss was accompanied by H2O2 generation, mitochondrial dysfunction, Caspase-9 activation and DNA nuclear morphology changes. Furthermore, the compound displayed the lowest IC50 on HT29-derived tumourspheres (0.70 μM), followed by HCT116 (1.77 μM) and SW620 (2.74 μM), impacting the HT29 tumoursphere formation by reducing their number and area. Finally, the compound displayed low cytotoxicity on AML12 hepatocytes without genotoxicity. Overall, sphaerococcenol A exhibits broad cytotoxic effects on different tumour cells, increasing H2O2 production and apoptosis. It also affects colorectal CSCs-enriched tumoursphere development. These data highlight the elevance to include sphaerococcenol A in further pharmacological studies aiming cancer treatments.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationCelso Alves, Joana Silva, Marta B. Afonso, Romina A. Guedes, Rita C. Guedes, Rebeca Alvariño, Susete Pinteus, Helena Gaspar, Márcia I. Goettert, Amparo Alfonso, Cecília M.P. Rodrigues, Maria C. Alpoím, Luis Botana, Rui Pedrosa, Disclosing the antitumour potential of the marine bromoditerpene sphaerococcenol A on distinct cancer cellular models, Biomedicine & Pharmacotherapy, Volume 149, 2022, 112886, ISSN 0753-3322, https://doi.org/10.1016/j.biopha.2022.112886pt_PT
dc.identifier.doi10.1016/j.biopha.2022.112886pt_PT
dc.identifier.issn0753-3322
dc.identifier.urihttp://hdl.handle.net/10400.8/7400
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherElsevierpt_PT
dc.relation.publisherversionhttps://www.sciencedirect.com/science/article/pii/S075333222200275Xpt_PT
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/pt_PT
dc.subjectAlgaept_PT
dc.subjectMarine natural productspt_PT
dc.subjectApoptosispt_PT
dc.subjectOxidative stresspt_PT
dc.subjectProteasomept_PT
dc.subjectCancer stem cellspt_PT
dc.titleDisclosing the antitumour potential of the marine bromoditerpene sphaerococcenol a on distinct cancer cellular modelspt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.citation.titleBiomedicine & Pharmacotherapypt_PT
oaire.citation.volume149pt_PT
person.familyNameAlves
person.familyNameSilva
person.familyNameAfonso
person.familyNameGuedes
person.familyNameGuedes
person.familyNameAlvariño
person.familyNamePinteus
person.familyNameGuerreiro Galla Gaspar
person.familyNameGoettert
person.familyNameAlfonso Rancaño
person.familyNameMartins de Carvalho Alpoim
person.familyNameBotana
person.familyNamePedrosa
person.givenNameCelso
person.givenNameJoana
person.givenNameMarta
person.givenNameRomina
person.givenNameRita
person.givenNameRebeca
person.givenNameSusete
person.givenNameHelena Margarida
person.givenNameMárcia Inês
person.givenNameMaria Amparo
person.givenNameMaria Carmen
person.givenNameLuis M
person.givenNameRui
person.identifier159091
person.identifier98885
person.identifier759648
person.identifier159292
person.identifierE-6798-2012
person.identifier174176
person.identifier349272
person.identifier.ciencia-id501C-F268-2E60
person.identifier.ciencia-id6317-6F15-BA35
person.identifier.ciencia-id401C-8C11-1B93
person.identifier.ciencia-id071D-9A56-51C5
person.identifier.ciencia-id741F-74C9-93AE
person.identifier.ciencia-id2210-4F3D-D329
person.identifier.ciencia-id661E-9677-74C5
person.identifier.ciencia-id761C-044C-995B
person.identifier.ciencia-id3711-340F-121F
person.identifier.ciencia-id2911-AA25-48B7
person.identifier.ciencia-id7A1F-13F5-19A8
person.identifier.ciencia-id4D1F-B0D3-9A92
person.identifier.ciencia-id3817-33DE-919E
person.identifier.orcid0000-0003-1581-2127
person.identifier.orcid0000-0003-1224-1699
person.identifier.orcid0000-0003-3011-4941
person.identifier.orcid0000-0002-4397-7968
person.identifier.orcid0000-0002-5790-9181
person.identifier.orcid0000-0001-8796-1389
person.identifier.orcid0000-0002-3290-3111
person.identifier.orcid0000-0002-1613-7023
person.identifier.orcid0000-0002-3648-5033
person.identifier.orcid0000-0003-1572-9016
person.identifier.orcid0000-0001-7273-9371
person.identifier.orcid0000-0003-2153-6608
person.identifier.orcid0000-0003-0970-0575
person.identifier.ridB-3366-2017
person.identifier.ridN-5202-2017
person.identifier.ridK-5836-2013
person.identifier.ridAAA-2858-2019
person.identifier.ridB-4815-2015
person.identifier.scopus-author-id55654969100
person.identifier.scopus-author-id56370819800
person.identifier.scopus-author-id55428400900
person.identifier.scopus-author-id55968950600
person.identifier.scopus-author-id7103388682
person.identifier.scopus-author-id55655328300
person.identifier.scopus-author-id7003891380
person.identifier.scopus-author-id7801528491
person.identifier.scopus-author-id7004586008
person.identifier.scopus-author-id7005010300
rcaap.rightsopenAccesspt_PT
rcaap.typearticlept_PT
relation.isAuthorOfPublicationba5ab7c2-7474-4ea9-9bf0-ca15fe42809a
relation.isAuthorOfPublication23e68f76-0f7a-4f39-9da8-f1a26e2e2cd7
relation.isAuthorOfPublication17c8f746-61ac-432c-915c-8c334f8809c4
relation.isAuthorOfPublicationf6241de1-32f2-43c0-b210-ef0fd22dd558
relation.isAuthorOfPublication5f54241a-1c76-467c-b4d7-e1b264542dd4
relation.isAuthorOfPublication7f1e24f4-81e8-4e54-a436-0905f74edf6d
relation.isAuthorOfPublicationdb45e9a7-9e25-4fbf-903e-9feac4a23d61
relation.isAuthorOfPublication580efc75-e17e-4380-ae50-e5bc1d0bc10d
relation.isAuthorOfPublication2a3ef057-0e1f-40ca-b781-d92d3b4314dc
relation.isAuthorOfPublicationefa7b266-e49a-4a2a-b586-50dc43b43e51
relation.isAuthorOfPublicationebaf5476-b6c1-40ff-88e7-d8fc7d52f2e7
relation.isAuthorOfPublication14e09dbf-dd1c-4c21-98cf-236ea18a9d54
relation.isAuthorOfPublication94496a40-57cf-472f-94e1-5db9d5da78b6
relation.isAuthorOfPublication.latestForDiscovery2a3ef057-0e1f-40ca-b781-d92d3b4314dc

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Alves et al_2022_Biomedicine & Pharmacotherapy.pdf
Size:
1.99 MB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.32 KB
Format:
Item-specific license agreed upon to submission
Description: